Crossmark Global Holdings Inc. increased its position in Amdocs Limited (NASDAQ:DOX - Free Report) by 34.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 145,556 shares of the technology company's stock after buying an additional 37,516 shares during the quarter. Crossmark Global Holdings Inc. owned 0.12% of Amdocs worth $12,733,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in DOX. State Board of Administration of Florida Retirement System raised its holdings in shares of Amdocs by 7.9% during the first quarter. State Board of Administration of Florida Retirement System now owns 166,927 shares of the technology company's stock valued at $16,030,000 after acquiring an additional 12,178 shares in the last quarter. Boston Trust Walden Corp boosted its stake in shares of Amdocs by 17.0% during the 2nd quarter. Boston Trust Walden Corp now owns 618,387 shares of the technology company's stock valued at $48,803,000 after purchasing an additional 89,726 shares in the last quarter. SG Americas Securities LLC boosted its stake in shares of Amdocs by 402.4% during the 2nd quarter. SG Americas Securities LLC now owns 154,968 shares of the technology company's stock valued at $12,230,000 after purchasing an additional 124,122 shares in the last quarter. Sargent Investment Group LLC purchased a new position in shares of Amdocs during the second quarter valued at about $289,000. Finally, Acadian Asset Management LLC raised its stake in Amdocs by 22.7% in the first quarter. Acadian Asset Management LLC now owns 1,395,894 shares of the technology company's stock worth $126,119,000 after buying an additional 258,343 shares in the last quarter. 92.02% of the stock is currently owned by institutional investors.
Amdocs Stock Up 0.0 %
Shares of NASDAQ DOX traded up $0.03 during midday trading on Friday, hitting $92.17. The stock had a trading volume of 492,889 shares, compared to its average volume of 474,845. The company has a market cap of $10.83 billion, a P/E ratio of 21.24, a PEG ratio of 1.47 and a beta of 0.74. The company has a quick ratio of 1.24, a current ratio of 1.24 and a debt-to-equity ratio of 0.21. The business's 50 day moving average is $87.92 and its 200-day moving average is $83.83. Amdocs Limited has a 52 week low of $74.41 and a 52 week high of $94.04.
Amdocs (NASDAQ:DOX - Get Free Report) last posted its quarterly earnings results on Wednesday, August 7th. The technology company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.60 by $0.02. Amdocs had a return on equity of 17.89% and a net margin of 10.21%. The firm had revenue of $1.25 billion during the quarter, compared to analysts' expectations of $1.25 billion. During the same quarter in the previous year, the business earned $1.41 earnings per share. The company's revenue was up 1.1% on a year-over-year basis. As a group, analysts predict that Amdocs Limited will post 5.67 EPS for the current year.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on DOX shares. Stifel Nicolaus assumed coverage on Amdocs in a report on Wednesday, October 2nd. They issued a "buy" rating and a $100.00 price objective for the company. StockNews.com raised shares of Amdocs from a "buy" rating to a "strong-buy" rating in a research note on Friday, October 25th. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, Amdocs presently has an average rating of "Buy" and a consensus target price of $102.00.
Get Our Latest Research Report on DOX
Amdocs Company Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.